Literature DB >> 11727084

Short-term outcome after laparoscopic and open 360 degrees fundoplication. A prospective randomized trial.

J Wenner1, G Nilsson, S Oberg, T Melin, S Larsson, F Johnsson.   

Abstract

BACKGROUND: Despite the lack of randomized trials supporting the laparoscopic approach, laparoscopic antireflux surgery has gained widespread acceptance during the last decade. The aim of this study was to compare the short-term symptomatic and objective outcome after laparoscopic and open 360 degrees fundoplication in a prospective randomized clinical trial.
METHODS: Sixty patients with GERD were randomized to undergo either laparoscopic (LF) or open 360 degrees fundoplication (OF). Endoscopy, esophageal manometry, 24-h pH monitoring, clinical symptom evaluation, and symptom scoring according to a validated questionnaire (the Gastrointestinal Symptom Rating Scale [GSRS]) was performed preoperatively and 6 months after surgery.
RESULTS: Five patients randomized to the laparoscopic group were converted to open surgery. Esophageal acid exposure was restored to normal in all patients. Lower esophageal sphincter length and resting pressure were significantly increased after both laparoscopic and open fundoplication (p < 0.001); there were no differences between the groups. No significant differences were seen in symptomatic outcome, although there was a trend toward a higher rate of mild dysphagia (p = 0.051) after laparoscopic surgery. GSRS revealed a decrease in reflux score (p < 0.001) and abdominal pain score (p < 0.001) postoperatively. There were no significant differences in GSRS scores between the two groups.
CONCLUSION: Laparoscopic 360 degrees fundoplication is as effective in treating reflux disease as open fundoplication. Six months postoperatively, no significant differences were seen in symptomatic or objective outcome. Long-term evaluation is needed.

Entities:  

Mesh:

Year:  2001        PMID: 11727084     DOI: 10.1007/s00464-001-9043-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  8 in total

1.  SAGES Appropriateness Conference: a summary.

Authors:  R E Glasgow; A Fingerhut; J Hunter
Journal:  Surg Endosc       Date:  2003-09-29       Impact factor: 4.584

Review 2.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

Review 3.  Minimally invasive surgery.

Authors:  B Jaffray
Journal:  Arch Dis Child       Date:  2005-05       Impact factor: 3.791

4.  Five-year subjective and objective results of laparoscopic and conventional Nissen fundoplication: a randomized trial.

Authors:  Werner A Draaisma; Hilda G Rijnhart-de Jong; Ivo A M J Broeders; Andre J P M Smout; Edgar J B Furnee; Hein G Gooszen
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

5.  Comparison of long-term outcome of laparoscopic and conventional nissen fundoplication: a prospective randomized study with an 11-year follow-up.

Authors:  Paulina T P Salminen; Heikki I Hiekkanen; Arto P T Rantala; Jari T Ovaska
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

6.  Open vs laparoscopic partial posterior fundoplication. A prospective randomized trial.

Authors:  B S Håkanson; K B A Thor; A Thorell; O Ljungqvist
Journal:  Surg Endosc       Date:  2006-11-21       Impact factor: 4.584

Review 7.  Evidence-based appraisal of antireflux fundoplication.

Authors:  Marco Catarci; Paolo Gentileschi; Claudio Papi; Alessandro Carrara; Renato Marrese; Achille Lucio Gaspari; Giovanni Battista Grassi
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

Review 8.  Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery.

Authors:  D Korolija; S Sauerland; S Wood-Dauphinée; C C Abbou; E Eypasch; M García Caballero; M A Lumsden; B Millat; J R T Monson; G Nilsson; R Pointner; W Schwenk; A Shamiyeh; A Szold; E Targarona; B Ure; E Neugebauer
Journal:  Surg Endosc       Date:  2004-04-27       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.